<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0025">
 <label>5</label>
 <element-citation publication-type="journal" id="sbref0025">
  <person-group person-group-type="author">
   <name>
    <surname>Indu</surname>
    <given-names>Purushothaman</given-names>
   </name>
   <name>
    <surname>Rameshkumar</surname>
    <given-names>MarimuthuRagavan</given-names>
   </name>
   <name>
    <surname>Arunagirinathan</surname>
    <given-names>Narasingam</given-names>
   </name>
   <name>
    <surname>Al-Dhabi</surname>
    <given-names>NaifAbdullah</given-names>
   </name>
   <name>
    <surname>Arasu</surname>
    <given-names>MariadhasValan</given-names>
   </name>
   <name>
    <surname>Ignacimuthu</surname>
    <given-names>Savarimuthu</given-names>
   </name>
  </person-group>
  <article-title>Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: a molecular docking and drug repurposing approach</article-title>
  <source>J Infect Public Health</source>
  <volume>13</volume>
  <issue>12</issue>
  <year>2020</year>
  <fpage>1856</fpage>
  <lpage>1861</lpage>
  <pub-id pub-id-type="pmid">33168456</pub-id>
 </element-citation>
</ref>
